Navigation Links
InNexus Biotechnology CEO to Present at BioContactQuebec 2008
Date:9/29/2008

uebec 2008

BioContactQuebec 2008 is a biopharmaceutical partnership symposium gathering over 1200 participants and more than 150 biopharmaceutical companies, coming from Canada, the United States, Asia and Europe, presenting in different sectors of activities (diagnostics, therapeutics and services) and disciplines such as cancer, immunology and inflammation.

About InNexus

InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL(TM) technology, which improves the potency of existing antibody products while opening new markets and disease applications. DXL(TM) antibodies utilize unique, novel and patented methods and technologies of InNexus.

InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in- house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit http://www.ixsbio.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release. This news release may contain assumptions, estimates, and other forward-looking statements that involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company's control that may cause actual results or performance to differ materially from those currently anticipated in such statements.


'/>"/>
SOURCE InNexus Biotechnology Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
2. InNexus Biotechnology Strengthens Patent Team With New Leadership
3. InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
6. Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
7. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
8. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
9. New Report on 633 Biotechnology Medicines Under Development Released in Michigan
10. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
11. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...sador to also Visit Detroit , ...Appia, French Ambassador for International Investm...Agency, , , , ,What: Ambassador Appia is availabl...s initiatives adopted by France to further develop...innovation and development., , ,When: Available fo...
(Date:11/24/2009)...rio,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesC...eeds,adivisionofThompsonsLimitedofBlenheim,Ontario...ciences,currentseedsbusinessasthecompanyanticipate...groSciencesHerbicideTolerantTraitTechnologyincorni...re. ,, "Thisacquisitionbringstogethertwostrongp...
(Date:11/24/2009)...th care employment grew by 29,000 jobs in October...stent growth during the U.S. recession. However, c...and health systems are coming closer to having to ...ministrators. , (Vocus) N...ed growing in October despite the shedding of jobs...
(Date:11/24/2009)...PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX...commercializingnovelpainmanagementtherapies,announ...iveOfficer,isscheduledtopresentatthe21stAnnualPipe...009atTheNewYorkPalaceHotelinNewYork,NewYork. ,,...er,willbeavailabletorespondtoquestionsduringthepre...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...y finds that physicians place importance on ...LTHAM, Mass., April 2, 2008 Given the recent,inve... marketing of biliary,stents for off-label uses in...l for device use in specific arteries could become...dy conducted by Millennium Research Group,at the S...
...obal Pharmaceutical Companies Select Drug Model...lization, MOUNTAIN VIEW, Calif., April 2, 2008 ,P...rovider of software,strategic consulting, and regu...opment, today announced that two Top 25 global pha...s Drug Model Explorer (DMX) software.,Scientists i...
...ributor in Greece, to Purchase an Aggregate ... BASKING RIDGE, N.J., April 1, 2008 Millennium,Bi...Millennium,Biotechnologies Group, Inc. (OTC Bullet...00,000 one year purchase order for the internation... Millennium received the,purchase order from Nutri...
Other Biology Technology:Off-Label Stent Use: How Important Are FDA Approvals to Physicians? 2Pharsight Signs Two New DMX(R) License Customers 2Pharsight Signs Two New DMX(R) License Customers 3Millennium Announces $200,000 Purchase Order From Greek Distributor 2Millennium Announces $200,000 Purchase Order From Greek Distributor 3
(Date:11/24/2009)...Medical Toxicology (ACMT) have signed an agreement... of Medical Toxicology (JMT), the official journa...eviously published by the University of Pennsylvan..., an international, peer-reviewed journal, is dedi...ical toxicology. The quarterly journal focuses on...
(Date:11/24/2009)...ew research on bacterial communities throughout si...e temporal patterns, suggesting that scientists co...g climate change in the polar regions. The study, ...ional Academy of Sciences Early Edition, shows th... synchronously over time, correlating with seasona...
(Date:11/23/2009)...09 Applied mathematicians dissected the morpholog...racteristic long leaf with a saddle-like arc midse...The simple cause of the lily,s fan-like shapeelast...ential growthwas revealed by using an equally simp...iang, a postdoctoral student at Harvard,s School o...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 1Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 2Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 3Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 1Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 2deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 1deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 2deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 3deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 4
...the global population living in cities reached 50 ...xciting new book series which brings together lead...ring and design communities from all over the worl...ange of issues facing the architects, planners, de...ies, and to encourage the integration of ecologica...
...yphimurium employ a startling array of techniques...s and produce illness. Through their expression o... physiologysuch microbes ingeniously adapt to vari...potential or virulence. , Although the study of ...w well advanced, many pieces of the puzzle are sti...
...iven to Bath, Imperial, London School of Economics...ester and Strathclyde Universities as a result of ...anchester University in partnership with Lancaster...pplications of graphene - a new form of ,super car...terial science, chemistry and engineering. , Exete...
Other Biology News:Springer looks ahead to the Future City 2The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 2The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 3The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 4The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 5EPSRC Science and Innovation Awards 2008 2EPSRC Science and Innovation Awards 2008 3EPSRC Science and Innovation Awards 2008 4
8 Channel Syringe Dispenser, 20 cc Capacity from Biosearch Technologies
Anti-sm (Smith Antigen) (SLE / Nuclear Marker) Ab-1 Monoclonal Antibody, Unconjugated from Lab Vision
Rat Anti-Mouse ZO-1 Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Chicken Anti-Opsin 1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: